ID   LONM_HUMAN              Reviewed;         959 AA.
AC   P36776; B3KPH8; D6W635; E5KMH8; F5GZ27; P36777; Q8N8K8; Q9UQ95;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2000, sequence version 2.
DT   28-JUN-2023, entry version 214.
DE   RecName: Full=Lon protease homolog, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03120};
DE            EC=3.4.21.53 {ECO:0000255|HAMAP-Rule:MF_03120};
DE   AltName: Full=LONHs;
DE   AltName: Full=Lon protease-like protein {ECO:0000255|HAMAP-Rule:MF_03120};
DE            Short=LONP {ECO:0000255|HAMAP-Rule:MF_03120};
DE   AltName: Full=Mitochondrial ATP-dependent protease Lon {ECO:0000255|HAMAP-Rule:MF_03120};
DE   AltName: Full=Serine protease 15 {ECO:0000255|HAMAP-Rule:MF_03120};
DE   Flags: Precursor;
GN   Name=LONP1 {ECO:0000255|HAMAP-Rule:MF_03120}; Synonyms=PRSS15;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION.
RC   TISSUE=Brain;
RX   PubMed=8248235; DOI=10.1073/pnas.90.23.11247;
RA   Wang N., Gottesman S., Willingham M.C., Gottesman M.M., Maurizi M.R.;
RT   "A human mitochondrial ATP-dependent protease that is highly homologous to
RT   bacterial Lon protease.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:11247-11251(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ILE-911.
RX   PubMed=20843780; DOI=10.1093/nar/gkq750;
RA   Wang W., Shen P., Thiyagarajan S., Lin S., Palm C., Horvath R.,
RA   Klopstock T., Cutler D., Pique L., Schrijver I., Davis R.W., Mindrinos M.,
RA   Speed T.P., Scharfe C.;
RT   "Identification of rare DNA variants in mitochondrial disorders with
RT   improved array-based sequencing.";
RL   Nucleic Acids Res. 39:44-58(2011).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Huang N.N., Maurizi M.R., Torres R.R., Polymeropoulos M.H., Lennon G.G.,
RA   Gottesman M.M.;
RT   "Chromosomal mapping and genomic organization of the ATP-dependent human
RT   LON protease gene.";
RL   Submitted (APR-1998) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 3-959 (ISOFORM 1), AND VARIANT ILE-911.
RC   TISSUE=Brain;
RX   PubMed=8119403; DOI=10.1016/0014-5793(94)80166-5;
RA   Amerik A.Y., Petukhova G.V., Grigorenko V.G., Lykov I.P., Yarovoi S.V.,
RA   Lipkin V.M., Gorbalenya A.E.;
RT   "Cloning and sequence analysis of cDNA for a human homolog of eubacterial
RT   ATP-dependent Lon proteases.";
RL   FEBS Lett. 340:25-28(1994).
RN   [9]
RP   SUBCELLULAR LOCATION.
RX   PubMed=7961901; DOI=10.1016/s0021-9258(19)62045-4;
RA   Wang N., Maurizi M.R., Emmert-Buck L., Gottesman M.M.;
RT   "Synthesis, processing, and localization of human Lon protease.";
RL   J. Biol. Chem. 269:29308-29313(1994).
RN   [10]
RP   DNA-BINDING.
RX   PubMed=9485316; DOI=10.1021/bi970928c;
RA   Fu G.K., Markovitz D.M.;
RT   "The human LON protease binds to mitochondrial promoters in a single-
RT   stranded, site-specific, strand-specific manner.";
RL   Biochemistry 37:1905-1909(1998).
RN   [11]
RP   FUNCTION.
RX   PubMed=12198491; DOI=10.1038/ncb836;
RA   Bota D.A., Davies K.J.;
RT   "Lon protease preferentially degrades oxidized mitochondrial aconitase by
RT   an ATP-stimulated mechanism.";
RL   Nat. Cell Biol. 4:674-680(2002).
RN   [12]
RP   DNA-BINDING, MUTAGENESIS OF SER-855, SUBUNIT, AND INTERACTION WITH TWNK AND
RP   POLG.
RX   PubMed=14739292; DOI=10.1074/jbc.m309642200;
RA   Liu T., Lu B., Lee I., Ondrovicova G., Kutejova E., Suzuki C.K.;
RT   "DNA and RNA binding by the mitochondrial lon protease is regulated by
RT   nucleotide and protein substrate.";
RL   J. Biol. Chem. 279:13902-13910(2004).
RN   [13]
RP   FUNCTION.
RX   PubMed=15870080; DOI=10.1074/jbc.m502796200;
RA   Ondrovicova G., Liu T., Singh K., Tian B., Li H., Gakh O., Perecko D.,
RA   Janata J., Granot Z., Orly J., Kutejova E., Suzuki C.K.;
RT   "Cleavage site selection within a folded substrate by the ATP-dependent lon
RT   protease.";
RL   J. Biol. Chem. 280:25103-25110(2005).
RN   [14]
RP   FUNCTION, AND DNA-BINDING.
RX   PubMed=17420247; DOI=10.1074/jbc.m611540200;
RA   Lu B., Yadav S., Shah P.G., Liu T., Tian B., Pukszta S., Villaluna N.,
RA   Kutejova E., Newlon C.S., Santos J.H., Suzuki C.K.;
RT   "Roles for the human ATP-dependent Lon protease in mitochondrial DNA
RT   maintenance.";
RL   J. Biol. Chem. 282:17363-17374(2007).
RN   [15]
RP   SUBSTRATE.
RX   PubMed=17579211; DOI=10.1210/me.2005-0458;
RA   Granot Z., Kobiler O., Melamed-Book N., Eimerl S., Bahat A., Lu B.,
RA   Braun S., Maurizi M.R., Suzuki C.K., Oppenheim A.B., Orly J.;
RT   "Turnover of mitochondrial steroidogenic acute regulatory (StAR) protein by
RT   Lon protease: the unexpected effect of proteasome inhibitors.";
RL   Mol. Endocrinol. 21:2164-2177(2007).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   MUTAGENESIS OF LYS-529; TRP-770; THR-880 AND 893-GLY-GLY-894.
RX   PubMed=24520911; DOI=10.1111/febs.12740;
RA   Ambro L., Pevala V., Ondrovicova G., Bellova J., Kunova N., Kutejova E.,
RA   Bauer J.;
RT   "Mutations to a glycine loop in the catalytic site of human Lon changes its
RT   protease, peptidase and ATPase activities.";
RL   FEBS J. 281:1784-1797(2014).
RN   [19]
RP   SUBUNIT.
RX   PubMed=25369343;
RA   Kereiche S., Kovacik L., Pevala V., Ambro L., Bellova J., Kutejova E.,
RA   Raska I.;
RT   "Three-dimensional reconstruction of the S885A mutant of human
RT   mitochondrial Lon protease.";
RL   Folia Biol. (Praha) 60:62-65(2014).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [21]
RP   INVOLVEMENT IN CODASS, AND VARIANTS CODASS TYR-631; SER-676; GLY-721 AND
RP   VAL-724.
RX   PubMed=25574826; DOI=10.1016/j.ajhg.2014.12.003;
RA   Strauss K.A., Jinks R.N., Puffenberger E.G., Venkatesh S., Singh K.,
RA   Cheng I., Mikita N., Thilagavathi J., Lee J., Sarafianos S., Benkert A.,
RA   Koehler A., Zhu A., Trovillion V., McGlincy M., Morlet T., Deardorff M.,
RA   Innes A.M., Prasad C., Chudley A.E., Lee I.N., Suzuki C.K.;
RT   "CODAS syndrome is associated with mutations of LONP1, encoding
RT   mitochondrial AAA+ Lon protease.";
RL   Am. J. Hum. Genet. 96:121-135(2015).
RN   [22]
RP   INVOLVEMENT IN CODASS, AND VARIANTS CODASS ALA-476; VAL-670; CYS-672;
RP   HIS-679; SER-749; GLU-767 AND ILE-927 DEL.
RX   PubMed=25808063; DOI=10.1002/ajmg.a.37029;
RA   Dikoglu E., Alfaiz A., Gorna M., Bertola D., Chae J.H., Cho T.J.,
RA   Derbent M., Alanay Y., Guran T., Kim O.H., Llerenar J.C. Jr., Yamamoto G.,
RA   Superti-Furga G., Reymond A., Xenarios I., Stevenson B., Campos-Xavier B.,
RA   Bonafe L., Superti-Furga A., Unger S.;
RT   "Mutations in LONP1, a mitochondrial matrix protease, cause CODAS
RT   syndrome.";
RL   Am. J. Med. Genet. A 167:1501-1509(2015).
RN   [23]
RP   CLEAVAGE OF TRANSIT PEPTIDE [LARGE SCALE ANALYSIS] AFTER GLY-67, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [24]
RP   SUBSTRATE.
RX   PubMed=28377575; DOI=10.1038/s41598-017-00632-8;
RA   Kunova N., Ondrovicova G., Bauer J.A., Bellova J., Ambro L.,
RA   Martinakova L., Kotrasova V., Kutejova E., Pevala V.;
RT   "The role of Lon-mediated proteolysis in the dynamics of mitochondrial
RT   nucleic acid-protein complexes.";
RL   Sci. Rep. 7:631-631(2017).
RN   [25]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 753-959, AND SUBUNIT.
RX   PubMed=20222013; DOI=10.1002/pro.376;
RA   Garcia-Nafria J., Ondrovicova G., Blagova E., Levdikov V.M., Bauer J.A.,
RA   Suzuki C.K., Kutejova E., Wilkinson A.J., Wilson K.S.;
RT   "Structure of the catalytic domain of the human mitochondrial Lon protease:
RT   proposed relation of oligomer formation and activity.";
RL   Protein Sci. 19:987-999(2010).
RN   [26]
RP   STRUCTURE BY ELECTRON MICROSCOPY (15 ANGSTROMS) OF MUTANT ALA-855, SUBUNIT,
RP   AND DOMAIN.
RX   PubMed=27632940; DOI=10.1038/srep33631;
RA   Kereiche S., Kovacik L., Bednar J., Pevala V., Kunova N., Ondrovicova G.,
RA   Bauer J., Ambro L., Bellova J., Kutejova E., Raska I.;
RT   "The N-terminal domain plays a crucial role in the structure of a full-
RT   length human mitochondrial Lon protease.";
RL   Sci. Rep. 6:33631-33631(2016).
CC   -!- FUNCTION: ATP-dependent serine protease that mediates the selective
CC       degradation of misfolded, unassembled or oxidatively damaged
CC       polypeptides as well as certain short-lived regulatory proteins in the
CC       mitochondrial matrix. May also have a chaperone function in the
CC       assembly of inner membrane protein complexes. Participates in the
CC       regulation of mitochondrial gene expression and in the maintenance of
CC       the integrity of the mitochondrial genome. Binds to mitochondrial
CC       promoters and RNA in a single-stranded, site-specific, and strand-
CC       specific manner. May regulate mitochondrial DNA replication and/or gene
CC       expression using site-specific, single-stranded DNA binding to target
CC       the degradation of regulatory proteins binding to adjacent sites in
CC       mitochondrial promoters (PubMed:12198491, PubMed:15870080,
CC       PubMed:17420247, PubMed:8248235). Endogenous substrates include
CC       mitochondrial steroidogenic acute regulatory (StAR) protein, helicase
CC       Twinkle (TWNK) and the large ribosomal subunit protein bL32m. bL32m is
CC       protected from degradation by LONP1 when it is bound to a nucleic acid
CC       (RNA), but TWNK is not (PubMed:17579211, PubMed:28377575).
CC       {ECO:0000255|HAMAP-Rule:MF_03120, ECO:0000269|PubMed:12198491,
CC       ECO:0000269|PubMed:15870080, ECO:0000269|PubMed:17420247,
CC       ECO:0000269|PubMed:17579211, ECO:0000269|PubMed:28377575,
CC       ECO:0000269|PubMed:8248235}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Hydrolysis of proteins in presence of ATP.; EC=3.4.21.53;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03120};
CC   -!- ACTIVITY REGULATION: Peptidase activity is subject to substrate
CC       inhibition by ATP. {ECO:0000269|PubMed:24520911}.
CC   -!- SUBUNIT: Homohexamer (PubMed:14739292, PubMed:25369343,
CC       PubMed:20222013). Organized in a ring with a central cavity
CC       (PubMed:25369343, PubMed:20222013). The ATP-binding and proteolytic
CC       domains (AP-domain) form a hexameric chamber, while the N-terminal
CC       domain is arranged as a trimer of dimers (PubMed:27632940). DNA and RNA
CC       binding is stimulated by substrate and inhibited by ATP binding.
CC       Interacts with TWNK and mitochondrial DNA polymerase subunit POLG
CC       (PubMed:14739292). {ECO:0000255|HAMAP-Rule:MF_03120,
CC       ECO:0000269|PubMed:14739292, ECO:0000269|PubMed:20222013,
CC       ECO:0000269|PubMed:25369343, ECO:0000269|PubMed:27632940}.
CC   -!- INTERACTION:
CC       P36776; P02666: CSN2; Xeno; NbExp=6; IntAct=EBI-357448, EBI-5260183;
CC       P36776-1; P36776-1: LONP1; NbExp=3; IntAct=EBI-25473602, EBI-25473602;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix {ECO:0000255|HAMAP-
CC       Rule:MF_03120, ECO:0000269|PubMed:7961901}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P36776-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P36776-2; Sequence=VSP_054617;
CC       Name=3;
CC         IsoId=P36776-3; Sequence=VSP_055310;
CC   -!- TISSUE SPECIFICITY: Duodenum, heart, lung and liver, but not thymus.
CC   -!- DOMAIN: The Lon N-terminal domains are crucial for the overall
CC       structure of the protein, maintaining it in a conformation allowing its
CC       proper functioning. {ECO:0000269|PubMed:27632940}.
CC   -!- DOMAIN: The AP-domain (ATP-binding and proteolytic domains) has a
CC       closed-ring conformation in the presence of AMP-PNP and its N-terminal
CC       entry gate appears closed. Upon ADP binding, it switches to a lock-
CC       washer conformation and its N-terminal gate opens.
CC       {ECO:0000269|PubMed:27632940}.
CC   -!- DOMAIN: The proteolytic site is connected to the ATP binding site
CC       through the GG loop (Gly-893 and Gly-894) and the loop containing Trp-
CC       770. Binding of a protein substrate such as beta-casein appears to
CC       trigger movement of both these loops as part of the conformational
CC       changes which lead to enhanced ATPase and peptidase activities.
CC       {ECO:0000305|PubMed:24520911}.
CC   -!- DISEASE: CODAS syndrome (CODASS) [MIM:600373]: A rare syndrome
CC       characterized by the combination of cerebral, ocular, dental,
CC       auricular, and skeletal features. These include developmental delay,
CC       craniofacial anomalies, cataracts, ptosis, median nasal groove, delayed
CC       tooth eruption, hearing loss, short stature, delayed epiphyseal
CC       ossification, metaphyseal hip dysplasia, and vertebral coronal clefts.
CC       {ECO:0000269|PubMed:25574826, ECO:0000269|PubMed:25808063}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the peptidase S16 family. {ECO:0000255|HAMAP-
CC       Rule:MF_03120}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA52291.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U02389; AAA61616.1; -; mRNA.
DR   EMBL; HQ204946; ADP90374.1; -; Genomic_DNA.
DR   EMBL; HQ204947; ADP90375.1; -; Genomic_DNA.
DR   EMBL; HQ204948; ADP90376.1; -; Genomic_DNA.
DR   EMBL; HQ204949; ADP90377.1; -; Genomic_DNA.
DR   EMBL; HQ204950; ADP90378.1; -; Genomic_DNA.
DR   EMBL; HQ204951; ADP90379.1; -; Genomic_DNA.
DR   EMBL; HQ204952; ADP90380.1; -; Genomic_DNA.
DR   EMBL; HQ204953; ADP90381.1; -; Genomic_DNA.
DR   EMBL; HQ204954; ADP90382.1; -; Genomic_DNA.
DR   EMBL; HQ204955; ADP90383.1; -; Genomic_DNA.
DR   EMBL; HQ204956; ADP90384.1; -; Genomic_DNA.
DR   EMBL; HQ204957; ADP90385.1; -; Genomic_DNA.
DR   EMBL; HQ204958; ADP90386.1; -; Genomic_DNA.
DR   EMBL; HQ204959; ADP90387.1; -; Genomic_DNA.
DR   EMBL; HQ204960; ADP90388.1; -; Genomic_DNA.
DR   EMBL; HQ204961; ADP90389.1; -; Genomic_DNA.
DR   EMBL; HQ204962; ADP90390.1; -; Genomic_DNA.
DR   EMBL; HQ204963; ADP90391.1; -; Genomic_DNA.
DR   EMBL; HQ204964; ADP90392.1; -; Genomic_DNA.
DR   EMBL; HQ204965; ADP90393.1; -; Genomic_DNA.
DR   EMBL; HQ204966; ADP90394.1; -; Genomic_DNA.
DR   EMBL; HQ204968; ADP90396.1; -; Genomic_DNA.
DR   EMBL; HQ204969; ADP90397.1; -; Genomic_DNA.
DR   EMBL; HQ204970; ADP90398.1; -; Genomic_DNA.
DR   EMBL; HQ204971; ADP90399.1; -; Genomic_DNA.
DR   EMBL; HQ204972; ADP90400.1; -; Genomic_DNA.
DR   EMBL; HQ204973; ADP90401.1; -; Genomic_DNA.
DR   EMBL; HQ204974; ADP90402.1; -; Genomic_DNA.
DR   EMBL; HQ204975; ADP90403.1; -; Genomic_DNA.
DR   EMBL; HQ204976; ADP90404.1; -; Genomic_DNA.
DR   EMBL; HQ204977; ADP90405.1; -; Genomic_DNA.
DR   EMBL; HQ204978; ADP90406.1; -; Genomic_DNA.
DR   EMBL; HQ204979; ADP90407.1; -; Genomic_DNA.
DR   EMBL; HQ204980; ADP90408.1; -; Genomic_DNA.
DR   EMBL; HQ204981; ADP90409.1; -; Genomic_DNA.
DR   EMBL; HQ204982; ADP90410.1; -; Genomic_DNA.
DR   EMBL; HQ204983; ADP90411.1; -; Genomic_DNA.
DR   EMBL; HQ204984; ADP90412.1; -; Genomic_DNA.
DR   EMBL; HQ204985; ADP90413.1; -; Genomic_DNA.
DR   EMBL; AF059309; AAD24414.1; -; Genomic_DNA.
DR   EMBL; AF059296; AAD24414.1; JOINED; Genomic_DNA.
DR   EMBL; AF059297; AAD24414.1; JOINED; Genomic_DNA.
DR   EMBL; AF059298; AAD24414.1; JOINED; Genomic_DNA.
DR   EMBL; AF059299; AAD24414.1; JOINED; Genomic_DNA.
DR   EMBL; AF059300; AAD24414.1; JOINED; Genomic_DNA.
DR   EMBL; AF059301; AAD24414.1; JOINED; Genomic_DNA.
DR   EMBL; AF059302; AAD24414.1; JOINED; Genomic_DNA.
DR   EMBL; AF059303; AAD24414.1; JOINED; Genomic_DNA.
DR   EMBL; AF059304; AAD24414.1; JOINED; Genomic_DNA.
DR   EMBL; AF059305; AAD24414.1; JOINED; Genomic_DNA.
DR   EMBL; AF059306; AAD24414.1; JOINED; Genomic_DNA.
DR   EMBL; AF059307; AAD24414.1; JOINED; Genomic_DNA.
DR   EMBL; AF059308; AAD24414.1; JOINED; Genomic_DNA.
DR   EMBL; AK056366; BAG51690.1; -; mRNA.
DR   EMBL; AK096626; BAC04829.1; -; mRNA.
DR   EMBL; AC011499; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471139; EAW69151.1; -; Genomic_DNA.
DR   EMBL; CH471139; EAW69154.1; -; Genomic_DNA.
DR   EMBL; BC000235; AAH00235.1; -; mRNA.
DR   EMBL; X74215; CAA52291.1; ALT_INIT; mRNA.
DR   EMBL; X76040; CAA53625.1; -; mRNA.
DR   CCDS; CCDS12148.1; -. [P36776-1]
DR   CCDS; CCDS62507.1; -. [P36776-3]
DR   CCDS; CCDS62508.1; -. [P36776-2]
DR   PIR; S42366; S42366.
DR   PIR; S57342; S57342.
DR   RefSeq; NP_001263408.1; NM_001276479.1. [P36776-2]
DR   RefSeq; NP_001263409.1; NM_001276480.1. [P36776-3]
DR   RefSeq; NP_004784.2; NM_004793.3. [P36776-1]
DR   PDB; 2X36; X-ray; 2.00 A; A/B/C/D/E/F=753-959.
DR   PDB; 6WYS; X-ray; 2.23 A; A/B/C=754-959.
DR   PDB; 6WZV; X-ray; 2.51 A; A/B/C=754-959.
DR   PDB; 6X1M; X-ray; 3.51 A; A/B/C=754-959.
DR   PDB; 6X27; X-ray; 2.12 A; A/B/C/D/E/F/G/H/I/J/K/L=754-959.
DR   PDB; 7KRZ; EM; 3.20 A; A/B/C/D/E/F=414-947.
DR   PDB; 7KSL; EM; 3.40 A; A/B/C/E/F=421-947.
DR   PDB; 7KSM; EM; 3.20 A; A/B/C/D/E/F=416-947.
DR   PDB; 7NFY; EM; 3.90 A; A/B/C/D/E/F=115-959.
DR   PDB; 7NG4; EM; 4.40 A; A/B/C/D/E/F=115-959.
DR   PDB; 7NG5; EM; 3.80 A; A/B/C/D/E/F=115-959.
DR   PDB; 7NGC; EM; 7.50 A; A/B/C/D/E/F=123-948.
DR   PDB; 7NGF; EM; 5.60 A; A/B/C/D/E/F=123-948.
DR   PDB; 7NGL; EM; 3.80 A; A/B/C/D/E/F=123-948.
DR   PDB; 7NGP; EM; 15.00 A; A/B/C/D/E/F=123-948.
DR   PDB; 7NGQ; EM; 12.00 A; A/B/C/D/E/F=123-948.
DR   PDB; 7OXO; EM; 3.90 A; A/B/C/D/E/F=1-959.
DR   PDB; 7P09; EM; 2.70 A; A/B/C/D/E/F=67-949.
DR   PDB; 7P0B; EM; 4.00 A; A/B/C/D/E/F=67-949.
DR   PDB; 7P0M; EM; 2.75 A; A/B/C/D/E/F=67-959.
DR   PDBsum; 2X36; -.
DR   PDBsum; 6WYS; -.
DR   PDBsum; 6WZV; -.
DR   PDBsum; 6X1M; -.
DR   PDBsum; 6X27; -.
DR   PDBsum; 7KRZ; -.
DR   PDBsum; 7KSL; -.
DR   PDBsum; 7KSM; -.
DR   PDBsum; 7NFY; -.
DR   PDBsum; 7NG4; -.
DR   PDBsum; 7NG5; -.
DR   PDBsum; 7NGC; -.
DR   PDBsum; 7NGF; -.
DR   PDBsum; 7NGL; -.
DR   PDBsum; 7NGP; -.
DR   PDBsum; 7NGQ; -.
DR   PDBsum; 7OXO; -.
DR   PDBsum; 7P09; -.
DR   PDBsum; 7P0B; -.
DR   PDBsum; 7P0M; -.
DR   AlphaFoldDB; P36776; -.
DR   SMR; P36776; -.
DR   BioGRID; 114762; 492.
DR   IntAct; P36776; 108.
DR   MINT; P36776; -.
DR   STRING; 9606.ENSP00000353826; -.
DR   BindingDB; P36776; -.
DR   ChEMBL; CHEMBL4879436; -.
DR   GuidetoPHARMACOLOGY; 3180; -.
DR   MEROPS; S16.002; -.
DR   MoonDB; P36776; Curated.
DR   GlyGen; P36776; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P36776; -.
DR   MetOSite; P36776; -.
DR   PhosphoSitePlus; P36776; -.
DR   SwissPalm; P36776; -.
DR   BioMuta; LONP1; -.
DR   DMDM; 12644239; -.
DR   EPD; P36776; -.
DR   jPOST; P36776; -.
DR   MassIVE; P36776; -.
DR   MaxQB; P36776; -.
DR   PaxDb; P36776; -.
DR   PeptideAtlas; P36776; -.
DR   ProteomicsDB; 24918; -.
DR   ProteomicsDB; 55221; -. [P36776-1]
DR   Antibodypedia; 811; 330 antibodies from 29 providers.
DR   DNASU; 9361; -.
DR   Ensembl; ENST00000360614.8; ENSP00000353826.2; ENSG00000196365.12. [P36776-1]
DR   Ensembl; ENST00000540670.6; ENSP00000441523.1; ENSG00000196365.12. [P36776-3]
DR   Ensembl; ENST00000593119.5; ENSP00000468541.1; ENSG00000196365.12. [P36776-2]
DR   GeneID; 9361; -.
DR   KEGG; hsa:9361; -.
DR   MANE-Select; ENST00000360614.8; ENSP00000353826.2; NM_004793.4; NP_004784.2.
DR   UCSC; uc002mcx.5; human. [P36776-1]
DR   AGR; HGNC:9479; -.
DR   CTD; 9361; -.
DR   DisGeNET; 9361; -.
DR   GeneCards; LONP1; -.
DR   HGNC; HGNC:9479; LONP1.
DR   HPA; ENSG00000196365; Tissue enhanced (adrenal).
DR   MalaCards; LONP1; -.
DR   MIM; 600373; phenotype.
DR   MIM; 605490; gene.
DR   neXtProt; NX_P36776; -.
DR   OpenTargets; ENSG00000196365; -.
DR   Orphanet; 1458; CODAS syndrome.
DR   Orphanet; 2140; Congenital diaphragmatic hernia.
DR   Orphanet; 79243; Pyruvate dehydrogenase E1-alpha deficiency.
DR   PharmGKB; PA162394145; -.
DR   VEuPathDB; HostDB:ENSG00000196365; -.
DR   eggNOG; KOG2004; Eukaryota.
DR   GeneTree; ENSGT00530000063553; -.
DR   HOGENOM; CLU_004109_1_1_1; -.
DR   InParanoid; P36776; -.
DR   OMA; YVGPPIY; -.
DR   OrthoDB; 1103874at2759; -.
DR   PhylomeDB; P36776; -.
DR   TreeFam; TF105001; -.
DR   BRENDA; 3.4.21.53; 2681.
DR   PathwayCommons; P36776; -.
DR   SignaLink; P36776; -.
DR   SIGNOR; P36776; -.
DR   BioGRID-ORCS; 9361; 817 hits in 1165 CRISPR screens.
DR   ChiTaRS; LONP1; human.
DR   EvolutionaryTrace; P36776; -.
DR   GeneWiki; LONP1; -.
DR   GenomeRNAi; 9361; -.
DR   Pharos; P36776; Tchem.
DR   PRO; PR:P36776; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; P36776; protein.
DR   Bgee; ENSG00000196365; Expressed in right adrenal gland and 191 other tissues.
DR   ExpressionAtlas; P36776; baseline and differential.
DR   Genevisible; P36776; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005759; C:mitochondrial matrix; IMP:UniProtKB.
DR   GO; GO:0042645; C:mitochondrial nucleoid; IDA:BHF-UCL.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0043531; F:ADP binding; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IMP:UniProtKB.
DR   GO; GO:0004176; F:ATP-dependent peptidase activity; IDA:UniProtKB.
DR   GO; GO:0070182; F:DNA polymerase binding; IPI:UniProtKB.
DR   GO; GO:0051880; F:G-quadruplex DNA binding; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0043560; F:insulin receptor substrate binding; IEA:Ensembl.
DR   GO; GO:0001018; F:mitochondrial promoter sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0042731; F:PH domain binding; IEA:Ensembl.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0003697; F:single-stranded DNA binding; IBA:GO_Central.
DR   GO; GO:0003727; F:single-stranded RNA binding; IDA:UniProtKB.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0034599; P:cellular response to oxidative stress; IDA:UniProtKB.
DR   GO; GO:0051131; P:chaperone-mediated protein complex assembly; IBA:GO_Central.
DR   GO; GO:0032042; P:mitochondrial DNA metabolic process; NAS:UniProtKB.
DR   GO; GO:0000002; P:mitochondrial genome maintenance; NAS:UniProtKB.
DR   GO; GO:0007005; P:mitochondrion organization; IMP:UniProtKB.
DR   GO; GO:0046627; P:negative regulation of insulin receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0070407; P:oxidation-dependent protein catabolic process; IMP:UniProtKB.
DR   GO; GO:0006515; P:protein quality control for misfolded or incompletely synthesized proteins; IBA:GO_Central.
DR   GO; GO:0051603; P:proteolysis involved in protein catabolic process; IDA:UniProtKB.
DR   GO; GO:0050730; P:regulation of peptidyl-tyrosine phosphorylation; IEA:Ensembl.
DR   GO; GO:0010044; P:response to aluminum ion; IEA:Ensembl.
DR   GO; GO:0009725; P:response to hormone; IEA:Ensembl.
DR   GO; GO:0001666; P:response to hypoxia; IEP:UniProtKB.
DR   CDD; cd19500; RecA-like_Lon; 1.
DR   Gene3D; 1.10.8.60; -; 1.
DR   Gene3D; 1.20.5.5270; -; 1.
DR   Gene3D; 1.20.58.1480; -; 1.
DR   Gene3D; 3.30.230.10; -; 1.
DR   Gene3D; 2.30.130.40; LON domain-like; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   HAMAP; MF_03120; lonm_euk; 1.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR003959; ATPase_AAA_core.
DR   InterPro; IPR004815; Lon_bac/euk-typ.
DR   InterPro; IPR008269; Lon_proteolytic.
DR   InterPro; IPR027065; Lon_Prtase.
DR   InterPro; IPR003111; Lon_prtase_N.
DR   InterPro; IPR046336; Lon_prtase_N_sf.
DR   InterPro; IPR027503; Lonm_euk.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR008268; Peptidase_S16_AS.
DR   InterPro; IPR015947; PUA-like_sf.
DR   InterPro; IPR020568; Ribosomal_S5_D2-typ_fold.
DR   InterPro; IPR014721; Ribosomal_S5_D2-typ_fold_subgr.
DR   PANTHER; PTHR43718; LON PROTEASE; 1.
DR   PANTHER; PTHR43718:SF2; LON PROTEASE HOMOLOG, MITOCHONDRIAL; 1.
DR   Pfam; PF00004; AAA; 1.
DR   Pfam; PF05362; Lon_C; 1.
DR   Pfam; PF02190; LON_substr_bdg; 1.
DR   PRINTS; PR00830; ENDOLAPTASE.
DR   SMART; SM00382; AAA; 1.
DR   SMART; SM00464; LON; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   SUPFAM; SSF88697; PUA domain-like; 1.
DR   SUPFAM; SSF54211; Ribosomal protein S5 domain 2-like; 1.
DR   PROSITE; PS51787; LON_N; 1.
DR   PROSITE; PS51786; LON_PROTEOLYTIC; 1.
DR   PROSITE; PS01046; LON_SER; 1.
DR   TIGRFAMs; TIGR00763; lon; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cataract; Deafness;
KW   Disease variant; DNA-binding; Dwarfism; Hydrolase; Mitochondrion;
KW   Nucleotide-binding; Protease; Reference proteome; Serine protease;
KW   Transit peptide.
FT   TRANSIT         1..67
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03120,
FT                   ECO:0007744|PubMed:25944712"
FT   CHAIN           68..959
FT                   /note="Lon protease homolog, mitochondrial"
FT                   /id="PRO_0000026734"
FT   DOMAIN          124..370
FT                   /note="Lon N-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01123"
FT   DOMAIN          759..949
FT                   /note="Lon proteolytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01122"
FT   REGION          77..102
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          218..257
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        218..233
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        241..255
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        855
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03120"
FT   ACT_SITE        898
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03120"
FT   BINDING         523..530
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03120"
FT   VAR_SEQ         1..196
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_055310"
FT   VAR_SEQ         42..105
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_054617"
FT   VARIANT         87
FT                   /note="E -> D (in dbSNP:rs34413649)"
FT                   /id="VAR_051564"
FT   VARIANT         241
FT                   /note="R -> Q (in dbSNP:rs11085147)"
FT                   /id="VAR_051565"
FT   VARIANT         476
FT                   /note="E -> A (in CODASS)"
FT                   /evidence="ECO:0000269|PubMed:25808063"
FT                   /id="VAR_073338"
FT   VARIANT         631
FT                   /note="S -> Y (in CODASS; dbSNP:rs879255248)"
FT                   /evidence="ECO:0000269|PubMed:25574826"
FT                   /id="VAR_073339"
FT   VARIANT         670
FT                   /note="A -> V (in CODASS; dbSNP:rs770036526)"
FT                   /evidence="ECO:0000269|PubMed:25808063"
FT                   /id="VAR_073340"
FT   VARIANT         672
FT                   /note="R -> C (in CODASS; dbSNP:rs777009012)"
FT                   /evidence="ECO:0000269|PubMed:25808063"
FT                   /id="VAR_073341"
FT   VARIANT         676
FT                   /note="P -> S (in CODASS; dbSNP:rs879255247)"
FT                   /evidence="ECO:0000269|PubMed:25574826"
FT                   /id="VAR_073342"
FT   VARIANT         679
FT                   /note="R -> H (in CODASS; dbSNP:rs549574673)"
FT                   /evidence="ECO:0000269|PubMed:25808063"
FT                   /id="VAR_073343"
FT   VARIANT         721
FT                   /note="R -> G (in CODASS; dbSNP:rs147588238)"
FT                   /evidence="ECO:0000269|PubMed:25574826"
FT                   /id="VAR_073344"
FT   VARIANT         724
FT                   /note="A -> V (in CODASS; dbSNP:rs879255249)"
FT                   /evidence="ECO:0000269|PubMed:25574826"
FT                   /id="VAR_073345"
FT   VARIANT         749
FT                   /note="P -> S (in CODASS)"
FT                   /evidence="ECO:0000269|PubMed:25808063"
FT                   /id="VAR_073346"
FT   VARIANT         767
FT                   /note="G -> E (in CODASS; dbSNP:rs562553348)"
FT                   /evidence="ECO:0000269|PubMed:25808063"
FT                   /id="VAR_073347"
FT   VARIANT         829
FT                   /note="A -> T (in dbSNP:rs35804229)"
FT                   /id="VAR_067708"
FT   VARIANT         911
FT                   /note="V -> I (in dbSNP:rs1062373)"
FT                   /evidence="ECO:0000269|PubMed:20843780,
FT                   ECO:0000269|PubMed:8119403"
FT                   /id="VAR_067709"
FT   VARIANT         927
FT                   /note="Missing (in CODASS)"
FT                   /evidence="ECO:0000269|PubMed:25808063"
FT                   /id="VAR_073348"
FT   MUTAGEN         529
FT                   /note="K->R: Abolishes ATPase activity, and presumably
FT                   ATP-driven protein unfolding, but does not block access to
FT                   the proteolytic active site or prevent a substrate from
FT                   binding to it."
FT                   /evidence="ECO:0000269|PubMed:24520911"
FT   MUTAGEN         770
FT                   /note="W->A: Has low basal, but normal stimulated ATPase
FT                   activity, and retains peptidase activity."
FT                   /evidence="ECO:0000269|PubMed:24520911"
FT   MUTAGEN         770
FT                   /note="W->P: Has normal basal, but low stimulated ATPase
FT                   activity, and abolishes peptidase activity."
FT                   /evidence="ECO:0000269|PubMed:24520911"
FT   MUTAGEN         855
FT                   /note="S->A: Lacks both ATPase and protease activity, but
FT                   retains DNA binding activity."
FT                   /evidence="ECO:0000269|PubMed:14739292,
FT                   ECO:0000269|PubMed:24520911"
FT   MUTAGEN         880
FT                   /note="T->V: Enhances the basal, but not the stimulated
FT                   ATPase activity."
FT                   /evidence="ECO:0000269|PubMed:24520911"
FT   MUTAGEN         893
FT                   /note="G->A: Has low basal, but normal stimulated ATPase
FT                   activity, and retains peptidase activity."
FT                   /evidence="ECO:0000269|PubMed:24520911"
FT   MUTAGEN         893
FT                   /note="G->P: Has normal basal, but low stimulated ATPase
FT                   activity, and abolishes peptidase activity."
FT                   /evidence="ECO:0000269|PubMed:24520911"
FT   MUTAGEN         894
FT                   /note="G->A,S: Enhances the basal, but not the stimulated
FT                   ATPase activity, and retains peptidase activity."
FT                   /evidence="ECO:0000269|PubMed:24520911"
FT   MUTAGEN         894
FT                   /note="G->P: Enhances the basal, but not the stimulated
FT                   ATPase activity, and abolishes peptidase activity."
FT                   /evidence="ECO:0000269|PubMed:24520911"
FT   CONFLICT        1..55
FT                   /note="MAASTGYVRLWGAARCWVLRRPMLAAAGGRVPTAAGAWLLRGQRTCDASPPW
FT                   ALW -> MAGLWRRALATCDCGERRGAGCCGGRCWPRRGAGSHCSRSVVAPRPADLRRL
FT                   SSLGTV (in Ref. 1; AAA61616)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        65..66
FT                   /note="WR -> CG (in Ref. 1; AAA61616)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        257..258
FT                   /note="EL -> DV (in Ref. 1; AAA61616)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        423
FT                   /note="E -> G (in Ref. 4; BAG51690)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        456
FT                   /note="N -> D (in Ref. 1; AAA61616)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        501
FT                   /note="I -> V (in Ref. 4; BAG51690)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        556
FT                   /note="A -> T (in Ref. 1; AAA61616)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        842
FT                   /note="L -> P (in Ref. 1; AAA61616)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        859
FT                   /note="T -> A (in Ref. 1; AAA61616)"
FT                   /evidence="ECO:0000305"
FT   HELIX           413..427
FT                   /evidence="ECO:0007829|PDB:7P09"
FT   HELIX           432..447
FT                   /evidence="ECO:0007829|PDB:7P09"
FT   STRAND          450..452
FT                   /evidence="ECO:0007829|PDB:7KSL"
FT   HELIX           453..467
FT                   /evidence="ECO:0007829|PDB:7P09"
FT   HELIX           480..490
FT                   /evidence="ECO:0007829|PDB:7P09"
FT   HELIX           495..511
FT                   /evidence="ECO:0007829|PDB:7P09"
FT   STRAND          518..522
FT                   /evidence="ECO:0007829|PDB:7P09"
FT   STRAND          524..528
FT                   /evidence="ECO:0007829|PDB:7KSL"
FT   HELIX           529..540
FT                   /evidence="ECO:0007829|PDB:7P09"
FT   STRAND          544..548
FT                   /evidence="ECO:0007829|PDB:7P09"
FT   HELIX           556..559
FT                   /evidence="ECO:0007829|PDB:7P09"
FT   STRAND          565..567
FT                   /evidence="ECO:0007829|PDB:7KSL"
FT   HELIX           572..580
FT                   /evidence="ECO:0007829|PDB:7P09"
FT   STRAND          582..584
FT                   /evidence="ECO:0007829|PDB:7KRZ"
FT   STRAND          586..590
FT                   /evidence="ECO:0007829|PDB:7P09"
FT   HELIX           592..594
FT                   /evidence="ECO:0007829|PDB:7P09"
FT   STRAND          599..601
FT                   /evidence="ECO:0007829|PDB:7P09"
FT   HELIX           603..611
FT                   /evidence="ECO:0007829|PDB:7P09"
FT   HELIX           613..616
FT                   /evidence="ECO:0007829|PDB:7P09"
FT   STRAND          617..619
FT                   /evidence="ECO:0007829|PDB:7P09"
FT   TURN            622..624
FT                   /evidence="ECO:0007829|PDB:7P0M"
FT   STRAND          626..628
FT                   /evidence="ECO:0007829|PDB:7P0M"
FT   STRAND          634..640
FT                   /evidence="ECO:0007829|PDB:7P09"
FT   HELIX           642..644
FT                   /evidence="ECO:0007829|PDB:7KRZ"
FT   HELIX           647..651
FT                   /evidence="ECO:0007829|PDB:7P09"
FT   STRAND          653..657
FT                   /evidence="ECO:0007829|PDB:7P09"
FT   HELIX           663..672
FT                   /evidence="ECO:0007829|PDB:7P09"
FT   HELIX           674..682
FT                   /evidence="ECO:0007829|PDB:7P09"
FT   TURN            686..688
FT                   /evidence="ECO:0007829|PDB:7P09"
FT   HELIX           693..702
FT                   /evidence="ECO:0007829|PDB:7P09"
FT   STRAND          706..709
FT                   /evidence="ECO:0007829|PDB:7P09"
FT   HELIX           712..728
FT                   /evidence="ECO:0007829|PDB:7P09"
FT   STRAND          733..736
FT                   /evidence="ECO:0007829|PDB:7P09"
FT   HELIX           739..741
FT                   /evidence="ECO:0007829|PDB:7P09"
FT   HELIX           742..746
FT                   /evidence="ECO:0007829|PDB:7P09"
FT   STRAND          750..753
FT                   /evidence="ECO:0007829|PDB:7KSL"
FT   STRAND          756..759
FT                   /evidence="ECO:0007829|PDB:7KSL"
FT   STRAND          764..786
FT                   /evidence="ECO:0007829|PDB:2X36"
FT   STRAND          799..804
FT                   /evidence="ECO:0007829|PDB:2X36"
FT   HELIX           808..828
FT                   /evidence="ECO:0007829|PDB:2X36"
FT   HELIX           834..837
FT                   /evidence="ECO:0007829|PDB:2X36"
FT   STRAND          839..843
FT                   /evidence="ECO:0007829|PDB:2X36"
FT   TURN            850..852
FT                   /evidence="ECO:0007829|PDB:2X36"
FT   HELIX           853..856
FT                   /evidence="ECO:0007829|PDB:2X36"
FT   HELIX           857..869
FT                   /evidence="ECO:0007829|PDB:2X36"
FT   STRAND          877..879
FT                   /evidence="ECO:0007829|PDB:2X36"
FT   STRAND          887..890
FT                   /evidence="ECO:0007829|PDB:2X36"
FT   HELIX           895..904
FT                   /evidence="ECO:0007829|PDB:2X36"
FT   STRAND          909..913
FT                   /evidence="ECO:0007829|PDB:2X36"
FT   HELIX           914..916
FT                   /evidence="ECO:0007829|PDB:2X36"
FT   HELIX           917..921
FT                   /evidence="ECO:0007829|PDB:2X36"
FT   HELIX           925..928
FT                   /evidence="ECO:0007829|PDB:2X36"
FT   STRAND          932..938
FT                   /evidence="ECO:0007829|PDB:2X36"
FT   HELIX           939..946
FT                   /evidence="ECO:0007829|PDB:2X36"
FT   HELIX           948..951
FT                   /evidence="ECO:0007829|PDB:6WZV"
FT   HELIX           952..956
FT                   /evidence="ECO:0007829|PDB:6X27"
SQ   SEQUENCE   959 AA;  106489 MW;  B5E03D9C27C220FF CRC64;
     MAASTGYVRL WGAARCWVLR RPMLAAAGGR VPTAAGAWLL RGQRTCDASP PWALWGRGPA
     IGGQWRGFWE ASSRGGGAFS GGEDASEGGA EEGAGGAGGS AGAGEGPVIT ALTPMTIPDV
     FPHLPLIAIT RNPVFPRFIK IIEVKNKKLV ELLRRKVRLA QPYVGVFLKR DDSNESDVVE
     SLDEIYHTGT FAQIHEMQDL GDKLRMIVMG HRRVHISRQL EVEPEEPEAE NKHKPRRKSK
     RGKKEAEDEL SARHPAELAM EPTPELPAEV LMVEVENVVH EDFQVTEEVK ALTAEIVKTI
     RDIIALNPLY RESVLQMMQA GQRVVDNPIY LSDMGAALTG AESHELQDVL EETNIPKRLY
     KALSLLKKEF ELSKLQQRLG REVEEKIKQT HRKYLLQEQL KIIKKELGLE KDDKDAIEEK
     FRERLKELVV PKHVMDVVDE ELSKLGLLDN HSSEFNVTRN YLDWLTSIPW GKYSNENLDL
     ARAQAVLEED HYGMEDVKKR ILEFIAVSQL RGSTQGKILC FYGPPGVGKT SIARSIARAL
     NREYFRFSVG GMTDVAEIKG HRRTYVGAMP GKIIQCLKKT KTENPLILID EVDKIGRGYQ
     GDPSSALLEL LDPEQNANFL DHYLDVPVDL SKVLFICTAN VTDTIPEPLR DRMEMINVSG
     YVAQEKLAIA ERYLVPQARA LCGLDESKAK LSSDVLTLLI KQYCRESGVR NLQKQVEKVL
     RKSAYKIVSG EAESVEVTPE NLQDFVGKPV FTVERMYDVT PPGVVMGLAW TAMGGSTLFV
     ETSLRRPQDK DAKGDKDGSL EVTGQLGEVM KESARIAYTF ARAFLMQHAP ANDYLVTSHI
     HLHVPEGATP KDGPSAGCTI VTALLSLAMG RPVRQNLAMT GEVSLTGKIL PVGGIKEKTI
     AAKRAGVTCI VLPAENKKDF YDLAAFITEG LEVHFVEHYR EIFDIAFPDE QAEALAVER
//
